Alterome Therapeutics, Inc.
Clinical trials sponsored by Alterome Therapeutics, Inc., explained in plain language.
-
First human test of targeted drug for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage trial is testing a new oral drug called ALTA2618 for people with advanced cancers that have a specific genetic mutation called AKT1 E17K. The study aims to find the safest and most effective dose and see how well the drug works against cancers like breast and end…
Phase: PHASE1 • Sponsor: Alterome Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New pill targets common cancer driver in advanced tumors
Disease control Recruiting nowThis early-stage trial is testing a new oral medication called ALTA3263 in adults with advanced solid tumors that have specific KRAS mutations. The study aims to find a safe dose and see how the body processes the drug, while also checking for early signs that it might help contr…
Phase: PHASE1 • Sponsor: Alterome Therapeutics, Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC